Industry calls for seat at reorganised GHTF table
This article was originally published in Clinica
Executive Summary
The group of medtech trade associations that participated in the Global Harmonization Task Force from its beginning strongly believe that industry can continue to provide valuable input to the forum and that it should have a seat at the table, Ralph Ives executive vice-president of Global Strategy and Analysis at the US medtech industry association, AdvaMed, an active player at the Global Medical Technology Alliance (GMTA), told Clinica.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.